FDC reports strong financial performance, increased income in fiscal year 2024-25

FDC Limited announced strong financial performance for the fiscal year 2024-25, with a total consolidated income of INR 2,19,878.12 lakhs, up from INR 2,04,457.53 lakhs in the previous year. The company's net profit reached INR 26,678.81 lakhs, with earnings per equity share standing at INR 16.39. On a standalone basis, total income was INR 2,17,563.03 lakhs and net profit was INR 27,362.60 lakhs. The EBITDA margin was reported at 20.6%.

The company declared an interim dividend of INR 5/- (500%) per equity share for FY 2024-25, totaling INR 81,40,50,420/-, which has been confirmed as the final dividend. This reflects FDC's commitment to delivering shareholder value amidst its expansion into new therapeutic areas and international markets.

FDC highlighted its strategic initiatives including increased R&D investment, capacity expansion across manufacturing units, and strengthening its supply chain. The company's focus on high-quality pharmaceutical solutions, regulatory compliance, and market responsiveness contributed to its consistent progress and sustained growth across India and international markets.